英国系统性硬化症流行病学研究:基于临床实践研究数据链的分析
该研究在临床实践研究数据链(CPRD)中开发并验证了两阶段病例确认策略,以评估英国系统性硬化症(SSc)的发病率、患病率、死亡率和诊断延迟。1999-2017年SSc总体发病率为10.7/百万/年(95%CI:9.9-11.4),女性高于男性;成人患病率为235.5/百万(95%CI:207.2-245.7);标准化死亡比为3.51(95%CI:3.19-3.84)。在先有雷诺现象(RP)编码后有SSc编码的患者中,22.4%(191/854)的滞后时间超过10年,提示诊断延迟仍是重要未满足需求。
要点
- 英国SSc总体发病率为10.7/百万/年,女性17.69/百万/年高于男性3.59/百万/年。
- 成人SSc患病率为235.5/百万,标准化死亡比为3.51,死亡率较高。
- 22.4%的患者从RP编码到SSc编码滞后超过10年,诊断延迟显著。
核心结论
- 在CPRD中开发并验证了两阶段病例确认策略,可有效识别SSc病例。
- 英国SSc发病率女性明显高于男性,死亡率显著升高。
- 从RP编码到SSc编码存在显著滞后,诊断延迟仍是重要未满足需求。
研究设计与样本
- 基于临床实践研究数据链(CPRD)设计并测试两阶段病例确认策略。
- 分析1999-2017年SSc的发病率、患病率、死亡率及诊断延迟。
主要发现
- 1999-2017年SSc总体发病率为10.7/百万/年(95%CI:9.9-11.4)。
- 女性发病率为17.69/百万/年(95%CI:16.32-19.07),男性为3.59/百万/年(95%CI:2.97-4.21)。
- 成人SSc患病率为235.5/百万(95%CI:207.2-245.7)。
- 平均死亡率为32/1000人年,标准化死亡比为3.51(95%CI:3.19-3.84)。
- 在854例先有RP编码后有SSc编码的患者中,191例(22.4%)滞后时间超过10年。
临床怎么用
- 在风湿免疫科临床中应关注RP患者向SSc的进展,尤其对长期RP患者保持警惕。
- SSc患者标准化死亡比高,需加强并发症监测和综合管理。
- 诊断延迟普遍,提示需优化RP患者的筛查和随访策略以早期识别SSc。
局限性
- 研究基于初级保健记录,可能受编码准确性和完整性的影响。
- 病例确认策略虽经测试,但仍可能存在漏诊或误分类。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We developed and tested a robust case ascertainment strategy within the Clinical Practice Research Datalink (CPRD), with the aim of assessing the incidence, prevalence, mortality and delay in diagnosis of SSc in the UK. METHODS: A two-stage case ascertainment strategy was devised and tested to establish a valid cohort of SSc cases within the CPRD. Incidence, prevalence and mortality statistics were analysed, alongside evaluation of the relationship between primary care codes for RP and SSc to examine diagnostic delay. RESULTS: SSc Read codes were identified in 3123 patients (from a study cohort of >10.1 million individuals). Of these, 1757 cases of SSc were identified using our case ascertainment approach. The overall incidence rate of SSc over the period between 1999 and 2017 was 10.7/million/year (95% CI: 9.9-11.4), being higher in females [17.69/million/year (95% CI: 16.32-19.07)] than in males [3.59/million/year (95% CI: 2.97-4.21)]. The overall prevalence of SSc in adults was 235.5/million (95% CI: 207.2-245.7). The mean rate of mortality was 32/1000 person-years, with an overall standardized mortality ratio of 3.51 (95% CI: 3.19-3.84). Of those with an initial code of RP prior to a Read code of SSc, 191/854 (22.4%) had a lag period of >10 years. CONCLUSION: We have developed and tested a robust case ascertainment strategy to examine the incidence, prevalence, mortality and diagnostic delay of SSc using primary care records of over 10 million UK residents. A significant lag between coding of RP and SSc in many patients suggests diagnostic delay in SSc remains an important unmet need.
引用
- Pauling JD, McGrogan A, Snowball J, et al. Epidemiology of systemic sclerosis in the UK: an analysis of the Clinical Practice Research Datalink. Rheumatology (Oxford). 2021. PMID: 33212504. doi:10.1093/rheumatology/keaa680
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。